相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reactivating aberrantly hypermethylated p15 gene in leukemic T cells by a phenylhexyl isothiocyanate mediated inter-active mechanism on DNA and chromatin
Shaohong Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
Joseph Pidala et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
Xiongpeng Zhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
Christophe Fremin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia
Hitoshi Suzushima et al.
LEUKEMIA RESEARCH (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
Azra Raza et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China
Jianmin Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics
Tara K. Gregory et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Anthracycline Dose Intensification in Acute Myeloid Leukemia
Hugo F. Fernandez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Bob Lowenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
Si-Xuan Qian et al.
LEUKEMIA RESEARCH (2007)
Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome
H Kantarjian et al.
CANCER (2006)
Aclarubicin and low-dose cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: A multicenter study of 112 Chinese patients
JM Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
C Schoch et al.
LEUKEMIA (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Treatment of relapsed and refractory acute myelogenous leukemia
EH Estey
LEUKEMIA (2000)
分享论文
